Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(S)-Tenofovir

Copy Product Info
😃Good
Catalog No. T12814Cas No. 147127-19-3
Alias (S)-TDF, (S)-PMPA, (S)-GS 1278

(S)-Tenofovir ((S)-PMPA) is the less active S-enantiomer of Tenofovir which is a nucleotide reverse transcriptase inhibitor.

(S)-Tenofovir

(S)-Tenofovir

Copy Product Info
😃Good
Purity: 99.9%
Catalog No. T12814Alias (S)-TDF, (S)-PMPA, (S)-GS 1278Cas No. 147127-19-3
(S)-Tenofovir ((S)-PMPA) is the less active S-enantiomer of Tenofovir which is a nucleotide reverse transcriptase inhibitor.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$30-In Stock
50 mg$40-In Stock
100 mg$60-In Stock
200 mg$88-In Stock
1 mL x 10 mM (in DMSO)$29-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.9%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

(S)-Tenofovir AI Summary
(S)-Tenofovir shows a selectivity index of 1.0 across various cell types and virus strains, suggesting an equal level of toxicity to both cells and viruses. It demonstrates antiviral activity against Camelpox viruses CML1 and CML14 in HEL299 cells and human PHK. However, the effective concentration (EC50) for inhibition of virus-induced cytopathic effects is greater than 176,000.0 nM, indicating relatively low potency in vitro. Additionally, the compound exhibits cytotoxicity against HEL299 cells and human PHK, with a cytotoxic concentration (CC50) above 176,000.0 nM, reflecting minimal toxicity towards these cell lines at the tested concentrations..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
(S)-Tenofovir ((S)-PMPA) is the less active S-enantiomer of Tenofovir which is a nucleotide reverse transcriptase inhibitor.
Synonyms(S)-TDF, (S)-PMPA, (S)-GS 1278
Chemical Properties
Molecular Weight287.21
FormulaC9H14N5O4P
Cas No.147127-19-3
SmilesC[C@@H](Cn1cnc2c(N)ncnc12)OCP(O)(O)=O
Relative Density.1.79 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 5 mg/mL (17.41 mM), Sonication and heating to 60℃ are recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4818 mL17.4089 mL34.8177 mL174.0886 mL
5 mM0.6964 mL3.4818 mL6.9635 mL34.8177 mL
10 mM0.3482 mL1.7409 mL3.4818 mL17.4089 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy (S)-Tenofovir | purchase (S)-Tenofovir | (S)-Tenofovir cost | order (S)-Tenofovir | (S)-Tenofovir chemical structure | (S)-Tenofovir formula | (S)-Tenofovir molecular weight